BACKGROUND: DNA aptamers are single-stranded nucleotide sequences that bind specifically to target molecules. By combining the advantages of PCR for amplifying specific DNA sequences and aptamer technology, we have developed a new strategy to detect target molecules such as proteins.
In 1990, 2 laboratories independently developed the technique of selecting nucleic acid-based ligands against target molecules from a pool of random sequences. Ellington and Szostak named the process "in vitro selection" and coined the term "aptamer" (from the Latin, aptus, meaning "fitting") (1 ) , and Tuerk and Gold used the term "SELEX" (systematic evolution of ligands by exponential enrichment) to describe the process (2 ) . Aptamers are actually oligonucleic acids, either single-stranded DNA (ssDNA) 3 or RNA, that fold into secondary and tertiary structures and bind with high affinity and specificity to different target molecules, such as proteins.
In the postgenomics era, there is an increasing demand for the detection of a wide range of proteins for basic research, drug discovery, and clinical applications, together with a need for increasingly lower detection limits. The ability shared by antibodies and aptamers to bind specifically to their target molecules makes them good candidates for molecular diagnostics. Aptamers have the advantages of ease of discovery, thermal stability, and low cost, making them very attractive for targeted protein assays (3 ) . Indeed, research into aptamer-based methods for diagnostics is currently the subject of considerable attention (4, 5 ) . Notably, 2 new methods based on affinity PCR, proximity ligation (6 ) and exonuclease-protection assay (7 ) , that incorporate aptamer binding and signal amplification by the PCR have achieved very low limits of quantification for protein detection. The key point of the affinity-based PCR approach is the ability to distinguish aptamer-protein complexes from unbound aptamers before signal amplification. Both of these methods rely on an extra ligation reaction that occurs preferentially on the aptamer-protein complex. Consequently, the ligation products are chemically differentiated from unbound aptamers, giving rise to an am-plifiable detection signal; however, potential falsepositive results can arise if ligation of the free aptamers takes place. Omitting the extra ligation reaction by applying rolling-circle amplification on a circular DNA aptamer has been suggested (3 ). Alternatively, an aptamer-protein complex could potentially be separated from unbound aptamers by means of capillary electrophoresis (8 ) .
We developed an assay that uses an aptamer-based regionally protected PCR (ARP-PCR) method and investigated the suitability of the assay to detect a selected target protein, ovine follicle-stimulating hormone ␣ subunit (oFSH␣), at picomolar or femtomolar concentrations.
Materials and Methods

PRIMERS
We designed 2 conserved primers that flank a candidate aptamer for PCR amplification: forward primer Pf (5Ј-ATACCAGCTTATTCAATA-3Ј) and reverse primer Pr (5Ј-AGATTGCACTTACTATCA-3Ј). We also prepared a Pf primer with a biotin group at the 5Ј end (Pfb) and a Pr primer modified with a phosphate group at the 5Ј end (Prph). Once we determined the sequence of a binding region, we designed a pair of primers to amplify the binding region via the PCR. In this study, we designed a reverse diagnostic primer (Pdr2) (5Ј-TCGCTCCATTAAATTCTC-3Ј) to pair with Pf for signal amplification via the PCR.
PREPARATION OF TARGET PROTEIN
FSH consists of 2 glycosylated subunits, ␣ and ␤. For this study, we prepared recombinant oFSH␣ (roFSH␣) as described previously to generate the aptamer (9 ) . roFSH containing both ␣ and ␤ subunits (roFSH␣␤) was also produced with transfected insect cells (High Five™; Invitrogen NZ) with the expressed protein secreted into serum-free culture medium. The roFSH␣␤ was demonstrated to be biologically active by in vitro bioassay (9 ) . A highly purified sheep pituitary gland extract of native oFSH (Ova2) was a gift of Dr. Lloyd Moore (AgResearch Invermay, Mosgiel, New Zealand). This material was comparable in biological activity to the highly purified oFSH RP2 standard produced by the National Hormone and Pituitary Program (USA), as assessed by both RIA and in vitro bioassay (9 ) . Both the roFSH␣␤ and Ova2 were used for characterization of the aptamer that had been generated against the roFSH␣.
GENERATION AND CHARACTERIZATION OF APTAMER
Initial ssDNA pool. A 96-base ssDNA oligomer (5Ј-ATACCAGCTTATTCAATA-N60-TGATAGTAAGT-GCAATCT-3Ј) from Invitrogen was used as an initial pool. The 60-mer nucleotide portion of randomized sequence (N60) was flanked by defined 18-nucleotide priming regions for PCR amplification. The ssDNA pool was reconstituted in 10 mmol/L Tris-HCl, pH 7.5, diluted to 1 mmol/L, and stored at Ϫ20°C until use.
Solid phase-bound target protein. Twenty pieces of nitrocellulose membrane (Hybond-C Extra; Amersham Biosciences/GE Healthcare) were cut into 2-mm squares, soaked with 50 g purified roFSH␣ in 50 L PBS (2.7 mmol/L KCl, 1.5 mmol/L KH 2 PO 4 , 137 mmol/L NaCl, and 8 mmol/L Na 2 HPO 4 , pH 7.2) containing 0.5 g/L sodium azide, air-dried, and stored at 4°C until use for selection.
Selection of aptamer.
Aptamers were generated by an in vitro evolutionary process that included several rounds of selection by target binding and mutation via mutagenesis PCR. In the first round, 3 L of the 1-mmol/L initial ssDNA pool was blocked with 500 L eastern blocking solution [50 g/L nonfat milk powder in eastern buffer containing 20 mmol/L Tris-HCl, pH 7.5, 100 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L MgCl 2 , 1 mmol/L CaCl 2 , 10 g/L yeast RNA (Roche) , and 1 mL/L NP-40] at room temperature for 1 h. Meanwhile, 1 piece of the Hybond-C Extra membrane bound with roFSH␣ was separately blocked with 500 L eastern blocking solution. This membrane was then transferred into the blocked ssDNA solution and incubated for 1 h at 4°C for maximum selection. The incubated membrane was washed 3 times (10 min each) with eastern buffer at room temperature to remove excess ssDNA. The ssDNA bound with target protein on the membrane was eluted at 80°C for 5 min with 30 L of Milli-Q-purified water (Millipore) as the template for the next round of PCR. The conditions for successive rounds were the same as for the first round except that the initial ssDNA pool was replaced by the succeeding candidate aptamer preparation (see below). All processes were performed at room temperature ( Fig. 1) .
Mutagenesis PCR. Random mutations in DNA fragments were generated with mixtures of deoxynucleoside triphosphates (dNTPs) and deoxyinosine triphosphate (dITP) in the PCR (10 ) . The PCR reaction contained 10 L of the eluted templates, 1 mol/L each of primers Pfb and Prph, 10 mmol/L Tris-HCl, pH 8. To optimize the product, we reduced the number of PCR cycles by 3 for every successive evolution round.
Preparation of candidate aptamer. The double-stranded PCR products were separated by agarose gel electrophoresis. The band of amplified fragments with the expected size was excised, purified with a QIAquick Gel Extraction Kit (Qiagen), and eluted with 50 L Milli-Q-purified water at pH 8.5 for each PCR reaction. The 5Ј-phosphorylated strand was removed from the purified double-stranded DNA (dsDNA) by enzymatic digestion at 37°C for 2 h in a reaction containing 5 U exonuclease (New England Biolabs), 67 mmol/L glycine-KOH (pH 9.4), 2.5 mmol/L MgCl 2 , and 50 mg/L BSA (Sigma-Aldrich). The reaction was then stopped, and the remaining strand that had been elongated from the biotinylated primer was extracted with chloroform. The presence of the generated ssDNA was monitored by UV spectrophotometry, and this preparation was used as the candidate aptamer preparation for the next selection round. From evolution round 10 onwards, we also used the candidate aptamer preparation for dot blotting to monitor the selection of aptamer.
Western, eastern, and dot blotting. We used western blotting to detect protein with an antibody and used eastern blotting to detect protein with an aptamer (11 ) . Both methods relate the results to the corresponding molecular weight of the protein. Protein samples were denatured and separated on a 150-g/L polyacrylamide gel by SDS-PAGE under reducing conditions and then electrophoretically transferred to a nitrocellulose membrane (Hybond-C; Amersham Pharmacia Biotech/GE Healthcare) in an alkaline transfer buffer (20 mL/L methanol, 25 mmol/L Tris, 190 mmol/L glycine) at 4°C. We also used dot blotting with either antibody or aptamer to detect folded protein without consideration of molecular weight. Protein samples were applied directly to a nitrocellulose membrane. The membranes were then blocked for 1 h at room temperature with either western blocking solution (50 g/L nonfat milk powder in western buffer containing 20 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, and 1 mL/L NP-40) followed by incubation with antibody to oFSH␣ (9 ) in western blocking solution at room temperature for 2 h, or eastern blocking solution followed by incubation with biotinylated aptamer in eastern blocking solution at room temperature for 2 h. Nonbound reagent (either primary antibody or biotinylated aptamer) was removed by washing 3 times (10 min each) with the corresponding western or eastern buffer. The washed membranes were incubated for 1 h at room temperature with either antirabbit IgGperoxidase conjugate (Sigma-Aldrich) diluted with 2000 volumes of western blocking solution or with streptavidin-peroxidase polymer (Sigma-Aldrich) diluted with 10 000 volumes of eastern buffer. Labeled bands were visualized with the Immun-Star HRP chemiluminescence kit (Bio-Rad Laboratories), photographed with a Molecular Imager Gel Doc XR system (Bio-Rad), and analyzed with Quantity One analysis software (version 4.6; Bio-Rad). The densities were The aptamers that bound to the target protein were subjected to selection and mutation before characterization by sequencing.
measured, when appropriate, with Scion Image software (Scion Corporation, Frederick, MD).
Aptamer clonal screening. We amplified the selected aptamers from evolution round 12 by high-fidelity PCR. The conditions were the same as for mutagenesis PCR except that dITP was omitted. Platinum Taq DNA polymerase (Invitrogen) and nonmodified primers (Pf and Pr) were used for 35 PCR cycles. The PCR products were purified with the QIAquick PCR Purification Kit (Qiagen) and ligated with the cloning vector pGEM-T Easy (Promega). This product was designated the pGEM-T Easy aptamer. The Escherichia coli DH5␣ strain was transformed with the pGEM-T Easy aptamer and selected with ampicillin. We confirmed the insertion by high-fidelity PCR with individual selected colonies as template and primers Pfb and Prph. The PCR product of each insert was separated by agarose gel electrophoresis and purified with a QIAquick Gel Extraction Kit, with 50 L Milli-Q-purified water, pH 8, being used in the elution step. The purified dsDNA was used for ssDNA preparation and subsequently screened by dot blotting (both as described above). The sequence of each positive clone identified by dot blotting was determined by DNA sequencing.
Targeting regional mapping. Each secondary structure of the sequenced aptamers was predicted with a DNAfolding program (12 ) . We selected different regions of the aptamer on the basis of the predicted secondary stem-loop structure and then synthesized these regions with biotin at their 5Ј ends (Invitrogen). We immobilized 100 ng of purified roFSH␣ and 3 L of culture media of roFSH␣␤ on nitrocellulose membranes to map the target-binding region of the aptamer by dot blotting. PBS, 100 ng BSA, and 3 L of untransfected null-cell culture media were used as negative controls.
Target-capture assay. Streptavidin magnetic beads (SMB) (New England Biolabs) coated with synthesized biotinylated ssDNA of the selected regions were used to capture the target protein in solution. We coated the SMB (160 g) with 80 pmol of each biotinylated candidate region according to the manufacturer's instructions. The beads were picked up with a PickPen (BioNobile) and transferred into 100 L eastern buffer containing 300 ng Ova2. The binding reaction was conducted at room temperature for 1 h. The SMB-regionOva2 complexes were transferred with a PickPen and washed 3 times with eastern buffer, resuspended in 10 L PBS, and loaded onto an SDS-PAGE gel for subsequent western blotting to determine the capturing ability of each biotinylated ssDNA region.
DETECTION OF TARGET PROTEIN BY ARP-PCR
Samples (1 L each) containing Ova2 at concentrations of 10
Ϫ8 to 10 Ϫ17 mol/L were incubated at room temperature for 1 h with the selected aptamer probe (1 L of 10 Ϫ7 mol/L) in 2 L eastern buffer. Serum from hypophysectomized sheep devoid of FSH (Hypox) as assessed by RIA (a gift from Norma Hudson, AgResearch, Wallaceville Animal Research Centre, New Zealand) and BSA were used as negative controls. Because the activity of DNase I for dsDNA is approximately 500 times higher than for ssDNA (13 ) , it was helpful to use primers Pdr2 and Pr and make both sequences double-stranded by complementary binding to the aptamer probes to ensure an efficient cleanup of (A), Dot blot for roFSH␣ incubated with a buffer without (panel 1) and with (panel 2) the candidates from evolution round 11. (B), Eastern blot for roFSH␣ (ra) detected by the candidates from evolution round 12 (lane 1). Pituitary oFSH (Ova2) was detected by the stem-loop region A62 (lane 2). One single band of glycosylated native oFSH␣ (na) was recognized, whereas the corresponding position of the ␤ subunit (nb) contained in Ova2 showed no signal.
Detection of Protein by Aptamer-Based PCR
the unbound sequences. Therefore, we added 0.2 pmol each of Pdr2 and Pr before adding freshly prepared 100 nmol MnCl 2 and 25 U DNase I (Roche); the total reaction volume was adjusted to 10 L with 20 mmol/L Tris-HCl, pH 7.5. Unbound sequences were digested at 37°C for 2 h and then heated at 80°C for 10 min to stop the reaction. The bound protein was detected by amplifying the protected binding region by high-fidelity PCR. The conditions were as described in the aptamerscreening section of the methodology except that in this case 3 primers (1 mol/L each of Pf and Pdr2, and 1.5 mol/L of Pr) and 1 L template from the 10-L digestion reaction were used. We then analyzed 20 L from each PCR reaction by electrophoresis on 30 g/L agarose gels and subsequent staining with SYBR Green (Molecular Probes/Invitrogen). The image was immediately visualized and photographed under UV light with the Molecular Imager Gel Doc XR system.
Results
GENERATION AND DETERMINATION OF APTAMER SEQUENCES
We generated the aptamers by an in vitro evolutionary process with a series of rounds of selection and mutation (Fig. 1) . Dot blotting was performed to monitor the presence of the candidate aptamers in the ssDNA preparation from the 10th round onward. A positive signal was detected at the 11th round of evolution (Fig. 2A) . The candidate aptamer generated from the 12th round was analyzed by eastern blotting, and a positive band of the expected molecular weight (approximately 16 kDa) was detected (lane 1 of Fig. 2B ). The results of both dot and eastern blotting suggested the generation of polyclonal aptamers capable of recognizing the target protein under nonreducing and reducing conditions. Furthermore, the individual sequence of the monoclonal aptamer was determined by DNA sequencing of the positive clones, which were screened by dot blotting (data not shown). Plasmid preparations of 20 positive colonies were sequenced. The sequence data revealed 11 different sequences with homologies ranging from 29% to 98%. The most abundant sequence, shared by 6 of the 20 clones and named A6, was chosen for further investigation (see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/ content/vol55/issue9).
TARGETING REGIONAL MAPPING
The DNA-folding program (12 ) predicted a potential secondary structure of aptamer A6 (Fig. 3) consisting of 2 stem-loop regions on the chosen aptamer sequence. To characterize the target-binding features of A6, we synthesized biotinylated oligonucleotides corresponding to the 2 stem-loop regions and named them A61 (5Ј-biotin-ATGGAGCGACATGGAGTC GGTCA-3Ј) and A62 (5Ј-biotin-CTTATTCAATACG GGGGAGAATT-3Ј). We also synthesized another sequence, A63 (5Ј-biotin-CTTATTCAATACGGGGG AGAATTTAATGGAGCGACATGGAGTCGGTCA-3Ј), that covered both the A61 and A62 regions. The A61, A62, and A63 oligonucleotides were used to evaluate their reactions with roFSH␣ and roFSH␣␤ by dot blotting. The results showed that the synthesized DNA fragments of the different aptamer regions exhibited different capacities. The signal from the A62 blot was substantially stronger than that from the A61 blot ( Fig.  4A) with either roFSH␣ or roFSH␣␤. The A63 sequence also showed a clearly positive signal, likely because the A62 region is included in the A63 sequence. Weak binding of A61 may also make a minor contribution to the A63 signal, which is approximately equal to the signal shown in the A61 dot (Fig. 4A) . The mapping results suggested that the A62 fragment was the main region on the A6 molecule binding to roFSH␣. Two regions of the stem-loop were designated A61 and A62. A diagnostic 41-mer segment was identified between primers Pf and Pdr2. A 87-mer between Pf and Pr was used as a control. A63 included both A61 and A62. A64 was located in the 3Ј region of A6.
The ability of A62 to bind to the native oFSH ␣ subunit from Ova2 was also demonstrated under reducing conditions. Ova2 contains native oFSH ␣ and ␤ subunits. Under such conditions, the ␣ subunit of 22-23 kDa would be dissociated from the ␤ subunit of 23-26 kDa (9 ) . Biotinylated A62 (20 pmol) recognized a single band of the glycosylated ␣ subunit without a signal from the ␤ subunit (lane 2 of Fig. 2B ). Note that the molecular weight of the native oFSH␣ due to glycosylation was higher than that of roFSH␣ expressed in E. coli with no posttranslational modification (lane 1 of Fig. 2B ).
TARGET-CAPTURING ASSAY
We further characterized aptamer A6 by examining each region that might react with Ova2 in solution. The remainder of the A6 sequence was synthesized and named A64 (5Ј-biotin-GGTCAGTTATGGCTTTGT GTGATAGTAAGTGCAATCTA-3Ј). SMB coated with the synthesized biotinylated region A61, A62, A63, or A64 were used to capture Ova2 in solution before detection by western blotting. The ability of each region to capture target protein was determined by measuring the density of the immunostaining signal from the western blot. The capacity of the A62 region to bind Ova2 was greater than that of A61, as had also been observed with the targeting regional mapping, whereas A64 has no detectable signal of binding to Ova2 (Fig.  4B) . The A63 region again showed a clearly positive signal, likely because of the A62 region being included in the A63 sequence. On the basis of the A62 sequence, we designed reverse diagnostic primer Pdr2 (5Ј-TCGCTCCATTAAATTCTC-3Ј) to pair with Pf for amplification of the binding region by the PCR.
DETECTION OF TARGET PROTEIN BY ARP-PCR
Both the dot-blotting and western-blotting results revealed that A62 was the main target-binding region. Oligonucleotide extensions from both ends of the binding region could therefore be designed without affecting aptamer-folding or -binding ability. In the case of the aptamer A6, it happened to already have the extensions (Fig. 3) . Therefore, the full length of A6 was used as a probe to bind to Ova2 in solution. The unbound sequence of the probe and all free aptamers in solution were removed by DNase I digestion. The aptamer region bound with protein, which was anticipated to be protected from DNase I cleavage (14 ) , was amplified specifically by the PCR. The 3 primers (Pf, Pdr2, and Pr, covering positions 1-18, 41-24, and 87-70, respectively of the aptamer probe) were present in every individual PCR reaction. With primers Pf and Pdr2, a diagnostic band of 41 bp was produced when the protein-binding region was protected from the complete DNase I digestion [lane 4 of Fig. 5A and the first 3 lanes (indicated mol/L could clearly be detected by the ARP-PCR assay (Fig. 5B) .
Discussion
The ARP-PCR technique we have described is a relatively straightforward approach for detecting proteins with high specificity and low limits of quantification. The key factor in this approach is to ensure that unbound aptamer is removed before the PCR amplification step. In the presence of Mg 2ϩ , DNase I makes single-strand nicks, and Mn 2ϩ maximally activates the activity of DNase I to cleave dsDNA (15 ) . Our ARP-PCR approach used oligonucleotides to form the complementary dsDNA portions on the aptamer probe. Importantly, the activity of DNase I on dsDNA is approximately 500 times higher than on ssDNA (13 ) . Therefore, with this approach only the targetbinding region was retained after DNase I digestion in the presence of Mg 2ϩ and Mn
2ϩ
. It was important to confirm that the amplified signal reflected only the targetbinding region surviving from the enzymatic digestion. Three primers (1 forward and 2 reverse) can be used for the ARP-PCR assay with an internal control. In our study, oFSH␣ was used as a model target, Pf was used as the forward primer, and Pdr2 and Pr were used as the reverse primers. We used the Pf and Pdr2 primers to amplify a 41-bp diagnostic fragment that included the targetbinding region. An 87-bp fragment could be amplified by priming with Pf and Pr as the internal control if DNase I cleavage was found to be incomplete. Excess Pr was included to avoid false-positive results. The approach of detecting proteins by aptamer-based PCR has shown that ARP-PCR can detect native oFSH at a concentration of 10 Ϫ14 mol/L without evidence of false-positive readouts. Future work will focus on developing a nonligation method for quantitative analysis of protein by incorporation of real-time PCR and aptamer technologies.
